Technologies
Title: | Anti-viral Drug |
Area: | Life Sciences & Biotechnology, COVID-19 Technology |
Focus Area: | Development of Repurposed Drugs for COVID-19 |
Developing Agency: | CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad |
Technology Readiness Index: | Commercialized |
| Website Link : | https://www.iictindia.org/ |
Brief Description
Description : | It has been identified that WHO approved drugs such as Paracetamol, Remdesivir, Hydroxychloroquine, Azithromycin, Flaviparavir, Lupinivir, etc. can be helpful for coronavirus treatment in India. IICT are fully equipped and will be carrying out repurposing of such drugs to COVID-19 treatment as per WHO norms. Research team has also been able to source about 200 Favipiravir tablets from Japan for comparative studies. |